Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
Current Clinical Pharmacology|April 22, 2010
Role of histone deacetylases and their inhibitors in cancer biology and treatmentJan H Beumer, Hussein Tawbi
Cancer Chemotherapy and Pharmacology|March 23, 2024
Pharmacology and pharmacokinetics of tazemetostatMarco Orleni, Jan H Beumer
Cancer Chemotherapy and Pharmacology|June 14, 2023
Pharmacology and pharmacokinetics of elacestrantJan H Beumer, Julia Foldi
Cancer Chemotherapy and Pharmacology|May 25, 2016
Therapeutic drug monitoring of 5-fluorouracilJames J Lee, Jan H Beumer, Edward Chu
Clinical Journal of the American Society of Nephrology : CJASN|March 21, 2019
Estimation of Kidney Function in Oncology: Implications for Anticancer Drug Selection and DosingMorgan A Casal, Thomas D Nolin, Jan H Beumer
Clinical Pharmacokinetics|January 25, 2006
Mass balance studies, with a focus on anticancer drugsJan H Beumer, Jos H Beijnen, Jan H M Schellens
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 12, 2008
Liquid chromatography-mass spectrometric assay for the quantitation in human plasma of ABT-888, an orally available, small molecule inhibitor of poly(ADP-ribose) polymeraseRobert A Parise, Mohammad Shawaqfeh, Merrill J Egorin, et al.
Rapid Communications in Mass Spectrometry : RCM|December 19, 2007
Quantitation of 5-fluorouracil (5-FU) in human plasma by liquid chromatography/electrospray ionization tandem mass spectrometryJuliann E Kosovec, Merrill J Egorin, Susanna Gjurich, et al.
Journal of Neuro-Oncology|January 7, 2009
Disposition of temozolomide in a patient with glioblastoma multiforme after gastric bypass surgeryDeric M Park, Dhvani D Shah, Merrill J Egorin, et al.
Pageof 20